Technical Analysis for PEN - Penumbra, Inc.

Grade Last Price % Change Price Change
grade B 141.86 2.47% 3.42
PEN closed up 0.85 percent on Thursday, January 17, 2019, on approximately normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical PEN trend table...

Date Alert Name Type % Chg
Jan 17 Crossed Above 200 DMA Bullish 2.47%
Jan 17 Pocket Pivot Bullish Swing Setup 2.47%
Jan 17 Upper Bollinger Band Walk Strength 2.47%
Jan 17 Above Upper BB Strength 2.47%
Jan 17 Overbought Stochastic Strength 2.47%
Jan 17 Up 3 Days in a Row Strength 2.47%
Jan 17 Up 4 Days in a Row Strength 2.47%
Jan 17 Upper Bollinger Band Touch Strength 2.47%
Jan 16 MACD Bullish Centerline Cross Bullish 3.34%
Jan 16 Pocket Pivot Bullish Swing Setup 3.34%

Older signals for PEN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in United States, Japan, and internationally. The company offers neurovascular access products under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, PXSLIM, and Velocity brands; and aspiration-based thrombectomy systems and accessory devices under the Penumbra System brand, as well as stent retriever for mechanical thrombectomy under the 3D brand. It also provides neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400 and Penumbra SMART Coil brands, as well as neurovascular stents under the LIBERTY Stent brand; neurosurgical tools for the removal of tissue and fluids under the Apollo System brand; detachable embolic coil systems for peripheral embolization under the RUBY Coil brand; detachable, microcatheter-deliverable occlusion devices under the POD (penumbra occlusion device) brand; and aspiration-based thrombectomy systems for peripheral applications under the Indigo System brand. The company sells its products through its salesforce and distributors to hospitals in the neuro and peripheral vascular markets. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.
Is PEN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 167.35
52 Week Low 88.8
Average Volume 370,037
200-Day Moving Average 138.3537
50-Day Moving Average 130.2146
20-Day Moving Average 124.272
10-Day Moving Average 128.411
Average True Range 5.932
ADX 12.37
+DI 26.2734
-DI 16.3778
Chandelier Exit (Long, 3 ATRs ) 121.334
Chandelier Exit (Short, 3 ATRs ) 128.636
Upper Bollinger Band 137.343
Lower Bollinger Band 111.201
Percent B (%b) 1.04
BandWidth 21.036114
MACD Line 1.5151
MACD Signal Line -0.7487
MACD Histogram 2.2637
Fundamentals Value
Market Cap 4.68 Billion
Num Shares 33.8 Million
EPS 0.15
Price-to-Earnings (P/E) Ratio 922.93
Price-to-Sales 11.15
Price-to-Book 8.79
PEG Ratio -71.69
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 144.64
Resistance 3 (R3) 144.18 141.65 143.60
Resistance 2 (R2) 141.65 140.08 141.88 143.26
Resistance 1 (R1) 140.05 139.10 140.85 140.51 142.91
Pivot Point 137.52 137.52 137.93 137.75 137.52
Support 1 (S1) 135.92 135.95 136.72 136.38 133.97
Support 2 (S2) 133.39 134.97 133.62 133.62
Support 3 (S3) 131.79 133.39 133.28
Support 4 (S4) 132.25